Karus Therapeutics Limited
Records under this name other than the patents Karus Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Karus Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,580,442 | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,938,290 | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,501,478 | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,200,007 | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,981,987 | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,513,530 | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,377,764 | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,442,815 | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,668,077 | Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,291,669 | Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent Formerly held In force · USPTO record | In force | USPTO record |